Clinical Trials Directory

Trials / Completed

CompletedNCT01329523

A Study to Compare Genetic Variations of IGF-I and IGF-II

A Non-Randomized Controlled Cross-Sectional Study to Compare Genetic Variations of IGF-I and IGF-II in Patients With Moderate to Severe Dementia and Younger Family Members, in Relation to Age-Matched Unaffected Controls

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Avera McKennan Hospital & University Health Center · Academic / Other
Sex
All
Age
50 Years – 81 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine if insulin-like growth factors (IGF) play a role in the development of dementia, specifically Alzheimer's disease (AD). The study will compare results from genetic testing between patients with AD and two other groups: younger biological family members of the AD patients and individuals without AD matched by age to the AD patients.

Conditions

Timeline

Start date
2010-11-01
Primary completion
2011-10-01
Completion
2011-10-01
First posted
2011-04-06
Last updated
2011-10-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01329523. Inclusion in this directory is not an endorsement.

A Study to Compare Genetic Variations of IGF-I and IGF-II (NCT01329523) · Clinical Trials Directory